Medtronic Capex To Revenue vs Operating Cash Flow Per Share Analysis
MDT Stock | USD 81.69 0.77 0.95% |
Medtronic PLC financial indicator trend analysis is infinitely more than just investigating Medtronic PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medtronic PLC is a good investment. Please check the relationship between Medtronic PLC Capex To Revenue and its Operating Cash Flow Per Share accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.
Capex To Revenue vs Operating Cash Flow Per Share
Capex To Revenue vs Operating Cash Flow Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medtronic PLC Capex To Revenue account and Operating Cash Flow Per Share. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Medtronic PLC's Capex To Revenue and Operating Cash Flow Per Share is -0.42. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Operating Cash Flow Per Share in the same time period over historical financial statements of Medtronic PLC, assuming nothing else is changed. The correlation between historical values of Medtronic PLC's Capex To Revenue and Operating Cash Flow Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Medtronic PLC are associated (or correlated) with its Operating Cash Flow Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Cash Flow Per Share has no effect on the direction of Capex To Revenue i.e., Medtronic PLC's Capex To Revenue and Operating Cash Flow Per Share go up and down completely randomly.
Correlation Coefficient | -0.42 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Most indicators from Medtronic PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medtronic PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.At this time, Medtronic PLC's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 458.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 7.5 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 21.5B | 20.5B | 23.6B | 24.8B | Total Revenue | 31.7B | 31.2B | 35.9B | 37.7B |
Medtronic PLC fundamental ratios Correlations
Click cells to compare fundamentals
Medtronic PLC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medtronic PLC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 90.7B | 93.1B | 91.0B | 90.9B | 104.6B | 109.8B | |
Short Long Term Debt Total | 24.8B | 26.4B | 24.1B | 24.4B | 28.0B | 29.4B | |
Other Current Liab | 5.6B | 6.1B | 6.1B | 6.1B | 7.0B | 7.3B | |
Total Current Liabilities | 10.4B | 8.5B | 12.4B | 9.1B | 10.4B | 10.9B | |
Total Stockholder Equity | 50.7B | 51.4B | 52.6B | 51.5B | 59.2B | 62.2B | |
Property Plant And Equipment Net | 4.8B | 5.2B | 5.4B | 5.6B | 6.4B | 6.7B | |
Net Debt | 20.7B | 22.8B | 20.4B | 22.8B | 26.2B | 27.6B | |
Retained Earnings | 28.1B | 28.6B | 30.3B | 30.4B | 35.0B | 36.7B | |
Cash | 4.1B | 3.6B | 3.7B | 1.5B | 1.8B | 1.6B | |
Non Current Assets Total | 68.7B | 70.5B | 67.9B | 69.3B | 79.7B | 83.6B | |
Non Currrent Assets Other | 1.6B | 1.7B | 2.0B | 2.3B | 2.7B | 2.8B | |
Cash And Short Term Investments | 10.9B | 10.8B | 10.6B | 8.0B | 9.2B | 4.8B | |
Net Receivables | 4.6B | 5.5B | 5.6B | 6.0B | 6.9B | 7.2B | |
Common Stock Shares Outstanding | 1.4B | 1.4B | 1.4B | 1.3B | 1.5B | 1.2B | |
Liabilities And Stockholders Equity | 90.7B | 93.1B | 91.0B | 90.9B | 104.6B | 109.8B | |
Non Current Liabilities Total | 29.5B | 33.0B | 25.9B | 30.2B | 34.8B | 36.5B | |
Inventory | 4.2B | 4.3B | 4.6B | 5.3B | 6.1B | 6.4B | |
Other Current Assets | 2.2B | 2.0B | 2.3B | 2.4B | 2.8B | 2.9B | |
Other Stockholder Equity | 26.2B | 26.3B | 24.6B | 24.6B | 28.3B | 29.7B | |
Total Liab | 39.8B | 41.5B | 38.3B | 39.3B | 45.2B | 47.4B | |
Total Current Assets | 22.0B | 22.5B | 23.1B | 21.7B | 24.9B | 26.2B | |
Short Term Debt | 2.8B | 11M | 3.7B | 20M | 23M | 21.9M | |
Intangible Assets | 19.1B | 17.7B | 15.6B | 14.8B | 17.1B | 17.9B | |
Accounts Payable | 2.0B | 2.1B | 2.3B | 2.7B | 3.1B | 3.2B | |
Other Liab | 6.7B | 5.8B | 5.5B | 6.8B | 7.8B | 3.9B | |
Other Assets | 2.1B | 3.5B | 1M | (1M) | (1.2M) | (1.1M) | |
Long Term Debt | 22.0B | 26.4B | 20.4B | 24.3B | 28.0B | 29.4B | |
Good Will | 39.8B | 42.0B | 40.5B | 41.4B | 47.6B | 50.0B | |
Short Term Investments | 6.8B | 7.2B | 6.9B | 6.4B | 7.4B | 5.0B | |
Accumulated Other Comprehensive Income | (3.6B) | (3.5B) | (2.3B) | (3.5B) | (3.1B) | (3.0B) | |
Common Stock | 134.1K | 134.5K | 133.1K | 133.1K | 119.8K | 113.8K | |
Property Plant Equipment | 4.8B | 6.2B | 5.4B | 6.6B | 7.6B | 8.0B | |
Property Plant And Equipment Gross | 5.8B | 5.2B | 13.4B | 14.1B | 16.2B | 17.0B | |
Short Long Term Debt | 2.8B | 11M | 3.7B | 20M | 18M | 17.1M | |
Net Tangible Assets | 50.7B | (8.3B) | (3.5B) | 51.5B | 59.2B | 62.2B | |
Deferred Long Term Liab | 1.2B | 1.0B | 884M | 708M | 637.2M | 605.3M | |
Noncontrolling Interest In Consolidated Entity | 135M | 174M | 171M | 182M | 209.3M | 123.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.